Pascal Sonnet

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Trypanosoma Cruzi

Methicillin Resistant Staphylococcus Aureus

Antimicrobial Resistance

Top Venues

Pharmaceuticals (Basel, Switzerland)

Future medicinal chemistry

Medicinal research reviews

Pathogens (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Romain Mustière, Alexandra Dassonville-Klimpt, Pascal Sonnet
Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases. Future medicinal chemistry 16 (13) (2024)
Romain Mustière, Alexandra Dassonville-Klimpt, Pascal Sonnet
Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases. Future medicinal chemistry 16 (13) (2024)
Romain Mustière, Alexandra Dassonville-Klimpt, Pascal Sonnet
Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases. Future medicinal chemistry 16 (13) (2024)
Laurie Bibens, Jean-Paul Becker, Alexandra Dassonville-Klimpt, Pascal Sonnet
A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Laurie Bibens, Jean-Paul Becker, Alexandra Dassonville-Klimpt, Pascal Sonnet
A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Laurie Bibens, Jean-Paul Becker, Alexandra Dassonville-Klimpt, Pascal Sonnet
A Review of Fatty Acid Biosynthesis Enzyme Inhibitors as Promising Antimicrobial Drugs. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Claudia Herrera-León, Francisco Ramos-Martín, Hassan El Btaouri, Viviane Antonietti, Pascal Sonnet, Laurent Martiny, Fabrizia Zevolini, Chiara Falciani, Catherine Sarazin, Nicola d'Amélio
The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide. Pharmaceutics 14 (5) (2022)
Jean Guillon, Anita Cohen, Clotilde Boudot, Sarah Monic, Solène Savrimoutou, Stéphane Moreau, Sandra Albenque-Rubio, Camille Lafon-Schmaltz, Alexandra Dassonville-Klimpt, Jean-Louis Mergny, Luisa Ronga, Mikel Bernabeu de Maria, Jeremy Lamarche, Cristina Dal Lago, Eric Largy, Valerie Gabelica, Serge Moukha, Pascale Dozolme, Patrice Agnamey, Nadine Azas, Catherine Mullié, Bertrand Courtioux, Pascal Sonnet
Design, Synthesis, and Antiprotozoal Evaluation of New Promising 2,9- Bis [(substituted-aminomethyl)]-4,7-phenyl-1,10-phenanthroline Derivatives, a Potential Alternative Scaffold to Drug Efflux. Pathogens (Basel, Switzerland) 11 (11) (2022)
N André Sasaki, Pascal Sonnet
A novel multi-target strategy to attenuate the progression of Parkinson's disease by diamine hybrid AGE/ALE inhibitor. Future medicinal chemistry 13 (24) (2021)
Christophe R Cantelli, Alexandra Dassonville-Klimpt, Pascal Sonnet
A review of current and promising nontuberculous mycobacteria antibiotics. Future medicinal chemistry 13 (16) (2021)
Marine Duplantier, Elodie Lohou, Pascal Sonnet
Quorum Sensing Inhibitors to Quench P. aeruginosa Pathogenicity. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Alexandra Dassonville-Klimpt, Pascal Sonnet
Advances in 'Trojan horse' strategies in antibiotic delivery systems. Future medicinal chemistry 12 (11) (2020)
Francisco Ramos-Martín, Claudia Herrera-León, Viviane Antonietti, Pascal Sonnet, Catherine Sarazin, Nicola d'Amélio
Antimicrobial Peptide K11 Selectively Recognizes Bacterial Biomimetic Membranes and Acts by Twisting Their Bilayers. Pharmaceuticals (Basel, Switzerland) 14 (1) (2020)
Elodie Lohou, N André Sasaki, Agnès Boullier, Marine Duplantier, Pascal Sonnet
Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 12 (4) (2019)
Thanh-Nhat Pham, Pauline Loupias, Alexandra Dassonville-Klimpt, Pascal Sonnet
Drug delivery systems designed to overcome antimicrobial resistance. Medicinal research reviews 39 (6) (2019)